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Abstract
The electron transport chain of mitochondria is a major source of reactive oxygen species (ROS),
which play a critical role in augmenting the Ca2+-induced mitochondrial permeability transition
(MPT). Mitochondrial release of superoxide anions (O2•-) from the intermembrane space (IMS) to
the cytosol is mediated by voltage dependent anion channels (VDAC) in the outer membrane. Here,
we examined whether closure of VDAC increases intramitochondrial oxidative stress by blocking
efflux of O2•- from the IMS and sensitizing to the Ca2+-induced MPT. Treatment of isolated rat liver
mitochondria with 5 µM G3139, an 18-mer phosphorothioate blocker of VDAC, accelerated onset
of the MPT by 6.8 ± 1.4 min within a range of 100–250 µM Ca2+. G3139-mediated acceleration of
the MPT was reversed by 20 µM butylated hydroxytoluene, a water soluble antioxidant. Pre-
treatment of mitochondria with G3139 also increased accumulation of O2•- in mitochondria, as
monitored by dihydroethidium fluorescence, and permeabilization of the mitochondrial outer
membrane with digitonin reversed the effect of G3139 on O2•- accumulation. Mathematical modeling
of generation and turnover of O2•- within the IMS indicated that closure of VDAC produces a 1.55-
fold increase in the steady-state level of mitochondrial O2•-. In conclusion, closure of VDAC appears
to impede the efflux of superoxide anions from the IMS, resulting in an increased steady-state level
of O2•-˜, which causes an internal oxidative stress and sensitizes mitochondria toward the Ca2+-
induced MPT.
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INTRODUCTION
Mitochondria are a major source of reactive oxygen species (ROS) in mammalian cells (1–5).
Superoxide anions (O2•-) generated by the mitochondrial respiratory chain are released from
both surfaces of the mitochondrial inner membrane (3,5–7). O2•- released into the matrix is
converted to H2O2 by mitochondrial Mn2+-dependent superoxide dismutase (SOD) (1–3,5,8,
9), and H2O2 so formed is further metabolized by matrix glutathione oxidoreductases,
peroxiredoxins, and peroxidases, thus completing the ROS detoxification cycle (1,3,9–13).
O2•- released into the intermembrane space (IMS) is oxidized by cytochrome c of the respiratory
chain (1–3,5,7,11,14) or exits into the cytosol to be eliminated by cytosolic Cu2+/Zn2+-
dependent SOD (3,8,9,13–16). Although, these reactions are sufficient to neutralize most
mitochondrially generated ROS, under pathological conditions excessive generation of O2•-
anions by Complex III can result in excess release of O2•- into the cytosol, oxidative stress and
cell injury (2–4,6,7,15,17). Water soluble hydrophilic O2•- does not freely diffuse across
phospholipid bilayers and most likely passes through the mitochondrial outer membrane via
voltage dependent anion channels (VDAC) (18–20).
The mitochondrial permeability transition (MPT) is induced by opening of high conductance
permeability transition (PT) pores in the mitochondrial inner membrane in response to
excessive Ca2+ uptake into mitochondria (21–25). PT pore opening permeabilizes the inner
membrane to solutes up to ~1500 Da and causes large amplitude mitochondrial swelling, inner
membrane depolarization, and uncoupling of oxidative phosphorylation (21,22). Inducers and
activators of the MPT include Ca2+, inorganic phosphate, alkaline pH, phenylarsine oxide,
diamide, atractyloside, mastoparan, and oxidative stress, whereas the immunosuppressive drug
cyclosporin A (CsA), Mg2+, low pH, and phospholipase inhibitors prevent PT pore opening
and consequent mitochondrial swelling (21,22,26–28). Frequently, oxidative stress acts
synergistically with other MPT inducers to promote PT pore opening (26–28).
Recently we hypothesized that alterations of mitochondrial function observed in mammalian
tissues under a variety of metabolic stresses may be due to VDAC closure, which limits the
normal flow of metabolites in and out of mitochondria (29,30). To further our understanding
of the consequences of VDAC closure on mitochondrial functions, we investigated the effect
of G3139, an 18-mer phosphorothioate oligonucleotide and recently described blocker of
VDAC (29–34), on Ca2+-induced PT pore opening and production of O2•- by isolated rat liver
mitochondria. Our data are consistent with the conclusion that the closure of VDAC in respiring
mitochondria impairs O2•- release from mitochondria, thus increasing intramitochondrial
oxidative stress and accelerating onset of the MPT. Numerical simulations suggest that 80%
closure of VDAC results in a 155% increase of intramitochondrial steady-state O2•-.
MATERIALS and METHODS
Animals
All animal protocols were approved by the Institutional Animal Care and Use Committee in
accordance with recommendations published in the Guide for the Care and Use of Laboratory
Animals, National Academic Press, Washington DC, 1996.
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Rat liver mitochondria were isolated from livers of overnight-fasted male Sprague-Dawley rats
(200–300 g) by differential centrifugation as described previously (35). Briefly, each liver was
quickly excised, diced and homogenized in 40 ml of buffer A (0.25 M sucrose, 2 mM HEPES,
0.5 mM EGTA, pH 7.4, adjusted with KOH). The homogenate was diluted with three volumes
of buffer A and centrifuged at 660 g for 15 min. The supernatant was carefully removed and
centrifuged at 9700 g for 10 min. The resulting pellet was resuspended and washed twice with
buffer B (0.25 M sucrose, 2 mM HEPES, pH 7.4, adjusted with KOH). Protein concentration
was adjusted to 50 mg protein/ml, and mitochondria were stored on ice for further use. The
mitochondrial protein was measured with a Bicinchonic Acid Protein Assay kit (Sigma, St.
Louis, MO, USA) using bovine serum albumin (BSA) as standard.
Mitochondrial swelling
Isolated rat liver mitochondria (1 mg/ml) were suspended in mitochondrial incubation buffer
(MIB) containing 200 mM sucrose, 5 mM succinate, 2 µM rotenone, 1 µg/ml oligomycin, 1
mM KH2PO4, 20 µM EGTA, 20 mM Tris/HEPES buffer, pH 7.4 and incubated 5 min at room
temperature (RT) with or without modifiers. Mitochondrial suspensions were then aliquoted
into 96-well clear microtiter plates (0.2 ml/well) and exposed to different Ca2+ concentrations
(0, 100, 150, 200, 250 and 300 µM). Absorbance at 544 nm was monitored using a FLUOStar
multi-well plate reader (BMG Labtech, Durham, NC, USA).
O2•- measurement
Isolated rat liver mitochondria (1 mg/ml) were suspended in MIB, incubated with and without
modifiers for 4 min at RT, and then treated with 2 µM dihydroethidium (DHE) (Invitrogen,
Eugene, OR, USA). After addition of DHE, mitochondria were incubated for another 1 min
and then added to microtiter plates containing the respiratory inhibitor antimycin A (1 µg/ml)
to promote O2•- production at Complex III (5–7). O2•- formation was inferred from increased
red fluorescence of ethidium (oxidized DHE) measured with excitation and emission
wavelengths of 485 nm and 610 nm, respectively (7). White 96-well microtiter plates were
used to maximize the sensitivity of the assay and prevent loss of fluorescent light through
transparent walls. The rate of O2•- production was expressed as relative fluorescent units
(RFU)/min/mg protein.
Distribution of ethidium in mitochondrial suspensions
Isolated rat liver mitochondria (1 mg/ml) were suspended in MIB and pre-treated with DHE
(2 µM) for 1 min at RT. Subsequently, antimycin A (1 µg/ml) was added, and mitochondria
were incubated for another 5 min at RT. After incubation, mitochondria were separated from
buffer by rapid centrifugation in a microfuge (14,000 rpm for 60 s). Supernatants were saved,
and mitochondrial pellets were resuspended in the initial volume of incubation buffer. Ethidium
fluorescence in supernatants and mitochondria was measured using white 96-well plates in the
fluorescence plate reader.
Mitochondrial outer membrane permeability
Isolated rat liver mitochondria (1 mg/ml) were suspended in MIB and pre-incubated with and
without modifiers for 5 min at RT. An aliquot of the suspension (500 µl) was quickly mixed
with calcein (40 µM) and layered over the 100 µl of silicone oil placed into a 1.5 ml Eppendorf
tube as described (36). The density of silicone oil was adjusted to 1.03 g/ml by mixing equal
volumes of two silicone oils with density 1.01 g/ml and 1.05 g/ml (Sigma, Cat # 10836 & Cat
# 175633). Immediately after layering the mitochondrial suspensions, the tubes were
centrifuged at 14,000 rpm for 60 s in an Eppendorf MiniSpin microcentrifuge (Eppendorf,
Westbury, NY) to sediment mitochondria into the silicone oil. After centrifugation, the upper
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aqueous layer was aspirated, and the walls of the Eppendorf tube were rinsed with incubation
buffer 3 times, leaving the mitochondrial pellet and oil layer undisturbed. The oil layer was
then aspirated, and the mitochondrial pellet was resuspended in 500 µl 0.1 % Triton X100,
sonicated for 30 s (Branson, Danbury, CT) and vortexed. The remaining silicone oil droplets
were removed by centrifugation (14,000 rpm for 60 s). Calcein fluorescence in the supernatant
was measured using white 96-well microtiter plates and excitation and emission wavelengths
of 495 nm and 520 nm, respectively.
Mitochondrial respiration
Oxygen consumption by isolated mitochondria was measured in MIB, using a Clark style
oxygen electrode, as described (29). Respiration was expressed as nmol O2/min/mg protein.
Materials
G3139 was a generous gift from Dr. Robert Brown (Genta, Inc, Berkeley Heights, NJ, USA).
Unless otherwise stated, all chemicals used in this study were obtained from Sigma (St. Louis,
MO, USA).
Statistics
Differences between groups were analyzed by 2-way ANOVA using p<0.05 as the criterion
of significance. Results were expressed as means ± S.E.M.. When error bars are not seen on
the graphs, they fall within the diameters of the symbols. Images are representative of at least
3 experiments.
RESULTS
Dose-dependence of the Ca2+-induced MPT
Typical absorbance changes of mitochondrial suspensions due to onset of the MPT after
treatment with different doses of Ca2+ are shown in Fig. 1A. In the absence of Ca2+, swelling
(decrease of absorbance) did not occur during the 45 min time of observation (Fig. 1A, curve
“a”, open circles). Increasing amounts of Ca2+ led to onset of swelling (MPT) at progressively
earlier time points, as manifested by decreasing absorbance after Ca2+ (Fig. 1A, curves “a”
through “f”,). The uniformity of the absorbance curves obtained for different concentrations
of added Ca2+ (Fig. 1A, curves “a”-”f”) and reproducibility of the maximal and minimal levels
of absorbance (Fig. 1A, dotted lines Amax & Amin) allowed quantitative comparison of MPT
between different samples. The time (T50%) to a 50% decrease of absorbance (A1/2) served
as a measure of the sensitivity of mitochondria to the Ca2+-induced MPT (Fig. 1B). CsA (1
µM), a PT pore inhibitor (37), blocked swelling at all concentrations of Ca2+ used, which
confirmed that swelling was due to opening of PT pores (Fig. 1A, curve “g”, filled triangles).
Effect of G3139 treatment on the Ca2+-induced MPT
Pretreatment of mitochondria with 5 µM G3139, a VDAC blocker (32–34), for 5 min
accelerated onset of the Ca2+-induced MPT and decreased T50% for swelling, although in the
absence of Ca2+, G3139 did not cause swelling (Fig. 2). On average, G3139 decreased T50%
by 6.8 ± 1.4 min over the entire range of Ca2+ concentrations used (Fig. 2B). This decrease of
T50% was equivalent to the decrease produced by increasing Ca2+ by 44 ± 5 µM Ca2+ (Fig.
2B). In the presence of G3139, CsA nonetheless retained its ability to inhibit Ca2+-induced
mitochondrial swelling (Fig. 2A, curve a), confirming that mitochondrial swelling in the
presence of G3139 was due to PT pore opening.
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Reversal by Butylated Hydroxytoluene of G3139-accelerated Mitochondrial Swelling
Oxidative stress sensitizes mitochondria to the Ca2+-induced MPT (28,38–40). In accordance,
butylated hydroxytoluene (BHT, 20 µM), an antioxidant, delayed Ca2+-induced mitochondrial
swelling 8.7 ± 0.5 min (Fig. 3A, compare open and closed circles, curves c and b). This increase
of T50% was equivalent to decreasing added Ca2+ by 60 ± 15 µM (Fig. 3A, compare open and
closed circles, curves c and b). The acceleration of MPT onset and decrease of T50% by G3139
was reversed by BHT (20 µM) added before induction of the MPT with Ca2+ (Fig. 3A, compare
curves a and d). The delay of MPT onset by BHT (20 µM) occurred for entire range of Ca2+
concentrations studied (Fig. 3B, compare curves c and b). Similarly, BHT reversed the effect
of G3139 at all Ca2+ concentrations studied (Fig. 3B, curves a and d, open triangles & open
squares, respectively).
Measurements of O2•- in mitochondria
We further tested the effect of G3139 on mitochondrial O2•-˜ production after antimycin A (1
µg/ml) treatment using DHE, a membrane permeable probe that reacts with O2•-˜ to form the
highly fluorescent ethidium cation (5–7). Rates of increase of ethidium fluorescence after
antimycin A were determined in control and G3139-treated mitochondria oxidizing succinate
in the presence and absence of added SOD. Antimycin A, an inhibitor of Complex III, was
used to increase mitochondrial O2•- production (5–7). G3139 (5 µM) increased antimycin A-
stimulated O2•- measured by DHE from 34.8 ± 2.5 to 54.2 ± 3.8 RFU/min/mg protein,
indicating a 55 ± 6% increase (Fig. 4, None and G3139). In both the presence and absence of
G3139, O2•- formation was not affected by SOD added to incubation media (Fig. 4, SOD),
indicating that the compartment forming O2•- and reacting with DHE was not accessible to
extramitochondrial SOD. Rapid separation of mitochondria from the incubation buffer by
microcentrifugation showed that ~95% of total ethidium fluorescence was associated with
mitochondria with the remainder in the supernatant (data not shown). Thus, ethidium
fluorescence was primarily reflecting O2•- formation within mitochondria.
Measurement of mitochondrial outer membrane permeability
To measure permeability of the mitochondrial outer membrane directly, we adopted a method
of rapid centrifugation of mitochondria through a layer of silicone oil, allowing fast separation
of mitochondria from the calcein-containing incubation buffer (36). During centrifugation,
mitochondria passing through silicone layer are stripped of their surrounding medium, but
calcein within the intermembrane space sediments with the mitochondria. In the absence of
G3139, calcein fluorescence associated with mitochondria was 22.6 ± 0.7 RFU/mg protein
(Fig. 5, None). When mitochondria were pre-treated with G3139 (5 µM), calcein fluorescence
associated with the sedimented mitochondria became 15.2 ± 0.6 RFU/mg protein, a decrease
of 35 ± 5% (Fig. 5, G3139). Digitonin (50 µM) pretreatment of mitochondria to permeabilize
the outer membrane (29,30,41,42) partially reversed this effect of G3139, but in the absence
of G3139 did not alter calcein retention (Fig. 5, Digitonin). These observations are consistent
with conclusion that G3139 decreases the permeability of the outer membrane to calcein,
consistent with inhibition of VDAC conductance.
Effect of G3139 treatment on the activity of Ca2+-uniporter
Treatment of isolated mitochondria with G3139 may interfere with Ca2+ uptake into
mitochondria and thus alter onset of the Ca2+-induced MPT. To initiate the MPT, respiration-
driven Ca2+ uptake must occur via the Ca2+ uniporter, and the rate of Ca2+-activated respiration
is a measure of the rate of mitochondrial Ca2+ uptake (25) . To assess the effect of G3139 on
the rate of Ca2+ uptake in mitochondria, we measured the initial rate of Ca2+-activated
mitochondrial respiration in the same medium used for swelling experiments (see Fig. 1–Fig.
3). Addition of Ca2+ (250 µM) to untreated mitochondria, increased respiration from 7.2 ± 0.2
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to 52.2 ± 2.6 nmol O2/min/mg protein, a 7-fold increase (Fig. 6, None). In the presence of
G3139, the initial rate of Ca2+-stimulated respiration increased from 5.5 ± 0.4 to 46.3 ± 1.0
nmol O2/min/mg protein, relative 8-fold increase, although the absolute rate of Ca2+-activated
respiration decreased by 11% (Fig. 6, G3139). These small differences in the rate of Ca2+
uptake into the mitochondria cannot account for the several minute delay of MPT onset by
G3139.
Mathematical model of superoxide metabolism in the mitochondrial intermembrane space
To estimate how the open-closed status of VDAC could affect steady state O2•- in the
mitochondrial intermembrane space, we developed a mathematical model, which is based on
our own and available experimental data. The mathematical model describes the steady state
level of O2•- within the intermembrane space (IMS) of mitochondria with open and closed
VDAC. Our model includes the following 4 processes of generation and annihilation of O2•-
within the IMS of mitochondria (Fig. 7):
1. Generation of O2•- by Complex III of the respiratory chain—The rate of change of
O2•- concentration in the IMS produced by Complex III (JRC) may be described as follows
(43):
(1)
where: kbc1 is the rate constant for superoxide generation by isolated antimycin A-treated
cytochrome bc1 (Complex III) (3); [bc1] is the concentration of cytochrome bc1(Fig. 7,
Complex III) in the mitochondrial inner membrane normalized to the total mitochondrial
protein (3,44), and Vmito/VIMS is the inverse fractional ratio of IMS of the total mitochondrial
volume.
The relationship between mitochondrial matrix volume (Vmito) and the volume of IMS
(VIMS) is determined by mitochondrial energetic status of and the tonicity of the incubation
buffer (45–47). Under our experimental conditions, we expect mitochondria to be in a
condensed configuration, and we assume that the IMS will represent one-half of the total
mitochondrial volume (45,46). Substitution of known parameters of mitochondria (Table 1)
into equation (1) produces a simplified equation describing changes of O2•- concentration
within the mitochondrial IMS:
(2)
2. O2•- dismutation—The IMS contains a negligible content of active SOD (4,8).
Accordingly in our model, we assume that only spontaneous non-enzymatic dismutation of
O2•- occurs (48):
(3)
The overall flux of superoxide dismutation at neutral pH can be expressed as (8):
(4)
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where: Jdis is the flux of superoxide anion dismutation, kdis is the second order rate constant
for superoxide dismutation, measured in µM−1s−1, and [O2•-] is O2•- concentration.
3. Oxidation of O2•- by cytochrome c within the mitochondrial IMS—O2•- released
into the IMS reacts with oxidized cytochrome c producing molecular oxygen and reduced
cytochrome c (1,2,14):
(5)
The equilibrium constant of this redox reaction can be expressed as Keq = kcyt c/k-cyt c =exp
(ΔEm·n·F/R·T), where Keq is the equilibrium constant, kcyt c and k-cyt c are the forward and
reverse rate constants, ΔEm is the difference of the midpoint potentials of the redox pairs
participating in the reaction, F is the Faraday’s constant, R is the gas constant, T is the absolute
temperature and n is the number of electrons transferred. To calculate the contribution of
cytochrome c mediated oxidation of O2•- in reaction (5), we used values of the midpoint
potentials for the pairs of cyt c(Fe3+)/cyt c(Fe2+) and O2/ O2•- determined in (49) and shown
in Table 1. The absolute values of midpoint potentials indicate that oxidized cytochrome c is
a strong oxidant and will act as an acceptor with high affinity for electrons and that O2• is strong
reducing agent with high capacity to donate electrons to oxidized cytochrome c. The
corresponding value of the equilibrium constant for reaction (5) calculated from these data
(Keq ~ 1.3·107) indicates the reaction is highly irreversible in the forward direction, allowing
simplification of the rate reaction to (5).
(6)
where: Jcyt c is the flux of O2•-, kcyt c is the forward rate constant, [O2•-˜] is the concentration
of O2•, and [cyt c (Fe3+)] is the concentration of oxidized cytochrome c. After reduction in the
IMS, reduced cytochrome c is rapidly re-oxidized by cytochrome c oxidase. Since cytochrome
c oxidase activity is so much greater that cytochrome c reduction by antimycin-inhibited
cytochrome bc1, virtually all cytochrome c remains in the oxidized state (50–52). Taking into
account the total concentration of cytochrome c in the IMS of liver mitochondria (44) we
estimated that the concentration of oxidized cyt c (Fe3+) approximates 700 µM, the value used
in our model in equation (6).
4. Efflux of O2•- through VDAC—The last process in O2•- metabolism is efflux of O2•-
through VDAC (JVDAC), which can be described as follows:
(7)
where: PVDAC (measured in s−1) is the permeability of VDAC for O2•-. The value of PVDAC
in intact mitochondria is unknown, and in our modeling we assume that G3139 at the doses
used in our work will induce an approximately 80% decrease in the conductance of VDAC, in
accord with recent observations (33,34).
Computational results
At steady state, the rate of change of O2•- concentration within the IMS is described by the
following equation:
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Substitution of fluxes and values of parameters (Table 1) into equation (8) allows derivation
of an expression for the steady state concentration of O2•- (in µM) as a function of VDAC
permeability (PVDAC)::
(9)
Numerical computations based on equation (9) produce a dependence of steady-state O2•-
concentration in the IMS on the VDAC permeability as shown in Fig. 8 (dotted line). The solid
portion of the curve (Fig. 8, solid line) shows that O2•- concentration within the IMS increases
from 0.0635 to 0.0985 µM when the permeability of VDAC (PVDAC) decreases by 80%, from
560 s−1 to 112 s−1.
DISCUSSION
Opening of mitochondrial PT pores initiates onset of the mitochondrial permeability transition
(MPT) with consequent mitochondrial depolarization, uncoupling of oxidative
phosphorylation and large amplitude mitochondrial swelling. Calcium, inorganic phosphate,
alkaline pH, oxidative stress and various oxidant chemicals promote PT pore opening, whereas
as cyclosporin A and pH less than 7 inhibit pore opening (21,22,26–28,40). The molecular
identity of the pore remains unresolved and controversial. In one model, the PT pore is a
complex of the adenine nucleotide transporter (ANT) from the inner membrane, cyclophilin
D (CypD) from the matrix and VDAC from the outer membrane. In this model, VDAC forms
part of the solute-conducting channel of the PT pore. Accordingly, we evaluated whether
inhibition of VDAC channel conductance with G3139, an 18-mer phosphorothioate
polyoligonucleotide inhibitior of mitochondrial VDAC (32–34,53), would block or delay PT
pore opening and onset of the MPT. However, contrary to expectation, G3139 accelerated onset
of the Ca2+-induced MPT, as manifested by a shortening of the time to half maximal swelling
(T50%) (Fig. 2). This acceleration of the Ca2+-induced MPT onset occurred at all Ca2+
concentrations examined. This result suggests that VDAC does not form part of the solute-
conducting channel of PT pores and is consistent with recent findings that the MPT still occurs
in mitochondria deficient of VDAC isoforms (54)
Although G3139 accelerated rather than blocked MPT onset, the polyoligonucleotide
nonetheless decreased permeability of the outer membrane to hydrophilic solutes as assessed
by rapid sedimentation through silicone oil. Centrifugal sedimentation separates individual
mitochondria from the bulk medium, except for an aqueous shell surrounding each
mitochondrion (36). Using calcein, a water soluble fluorophore that crosses the outer but not
the inner membrane through VDAC into the IMS, we showed that G3139 decreased the amount
of calcein sedimenting with mitochondria through silicone in a fashion that was largely
reversed by outer membrane disruption with digitonin (Fig. 5). These results show that G3139
blocks access of calcein to a space opened by digitonin, namely the IMS. Since access to the
IMS is provided by VDAC, we can conclude that G3139 does indeed inhibit VDAC in our
isolated rat liver mitochondria, as shown previously for VDAC in reconstituted bilayers (31,
33,34,53). Digitonin, however, did not completely restore the initial level of calcein
sedimenting with mitochondria through silicone oil (Fig. 5). Digitonin causes vesiculation of
the outer membrane (41,44). Some of these vesicles remain attached to mitochondria. In the
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presence of G3139, these vesicles may exclude calcein, which would explain the lack of full
recovery of calcein sedimentation.
Mitochondrial Ca2+ uptake, the initiating factor for onset of the MPT, might also be affected
by VDAC closure. To assess this possibility, we estimated rates of mitochondrial Ca2+ uptake
from rates of Ca2+-stimulated respiration. G3139 decreased Ca2+ -induced respiration by only
11% (Fig. 6, Ca2+/G3139). This small G3139-induced decrease of the rate of Ca2+ uptake
might slightly delay MPT onset, but to the contrary G3139 accelerated MPT onset. Thus, effects
on Ca2+ uptake do not explain G3139-dependent acceleration of MPT onset.
The mitochondrial electron transport chain is a major source of intracellular ROS, including
O2•-(1,2,5,6). Normally, the respiratory chain releases O2•- from both sides of the inner
membrane, namely to the matrix and the IMS. In the matrix, mitochondrial superoxide
dismutase, catalase, glutathione peroxidases and peroxiredoxins detoxify O2•- and H2O2 (1,
3,4,7,9,11,20). For O2•- released into the IMS, O2•-˜ is principally detoxified via oxidation by
cytochrome c or by cytosolic SOD after release into the cytosol. O2•-˜ is hydrophilic and
negatively charged and therefore must cross the outer membrane via VDAC (18–20).
Accordingly, VDAC may be an important regulator of O2•- diffusion from the IMS to the
cytosol (19), and O2•- retention after VDAC closure may cause intramitochondrial oxidative
stress and promote onset of the MPT while simultaneously protecting the cytosol against
oxidative stress (30).
To test the hypothesis that increased oxidative stress after VDAC closure with G3139 was
accelerating the MPT, we evaluated the effect of the antioxidant, BHT, on the G3139-
accelerated MPT onset. In the absence of G31239 or BHT, Ca2+ induced characteristic S-
shaped mitochondrial swelling as monitored by absorbance of mitochondrial suspensions (Fig.
1A) and expressed as the time required for a 50% change (T50%) to occur (Fig. 2B). As
Ca2+ increased, T50% decreased. G3139 further accelerated MPT onset to extent comparable
to that after increasing added Ca2+ by 44 ± 5 µM The antioxidant, BHT, reversed acceleration
of the MPT by G3139 and also delayed the MPT in the absence of G3139 (Fig. 3). Consistent
with earlier studies (17,28), these results suggested that ROS are involved in onset of the
Ca2+-induced MPT.
To address directly the effect of G3139 on mitochondrial ROS generation, we measured O2•-
production using DHE. Nonfluorescent DHE reacts with O2•- to form red-fluorescing ethidium
(55–57). To enhance O2•- formation, mitochondria were treated with antimycin in the presence
of succinate and rotenone. Under these conditions, O2•- is principally released by Complex III
into the IMS. (1,3,6,7). After release of O2•- into the extramitochondrial space, O2•- becomes
diluted by more than a 1000-fold and is further decreased by spontaneous dismutation.
Accordingly, ethidium generation predominantly occurs within the IMS where modeling
indicates that O2•- concentration is 0.5–2 µM or near the surface of mitochondria where local
O2•- concentrations are highest. This interpretation is supported by the observation that
exogenous SOD, an enzyme that degrades O2•- in the extramitochondrial space, did not alter
generation of ethidium fluorescence (Fig. 4) In antimycin-treated mitochondria, G3139
increased the rate of ethidium formation by 75±7%, which was reversed by outer membrane
permeabilization with digitonin (Fig. 4). These results are consistent with the conclusion that
G3139 by blocking VDAC causes an increase of O2•- in the IMS. However, closure of VDAC
by itself was not sufficient to initiate the MPT in isolated mitochondria and required increased
Ca2+ loading. Ca2+ may have the dual role of both opening PT pores in a CypD-dependent
fashion and of promoting mitochondrial ROS generation (1,22,26,27,58).
Mathematical modeling was used to assess the expected effect of VDAC closure on O2•- levels
in the IMS. According to the model, steady-state [O2•-] increases exponentially with
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progressive closure of VDAC. For the reported maximal 80% closure of reconstituted VDAC
by G3139 (33,34,53,59), VDAC permeability changes from 560 s−1 to 112 s−1, leading to 55%
increase in [O2•] after G3139, in good agreement with our experimental findings (Fig. 4). After
100% VDAC closure (PVDAC = 0 s−1), the mathematical model predicts a 2.4-fold increase of
[O2•-] from 0.047 to 0.114 µM O2•- does not increase above this concentration because of
oxidation by cytochrome c and spontaneous dismutation.
In conclusion, opening and closing of the VDAC pathways may be important to regulate both
intramitochondrial O2•- levels and the release of O2•- from mitochondrial into the cytosol.
Although ROS can induce cell injury, increasing evidence indicates a role for ROS as a vital
intracellular signal (1–5). Thus, VDAC may regulate release of ROS signals in normal cellular
physiology (1,4,5,13). In this way, opening and closure of VDAC can provide a simple and
flexible mechanism of transduction of extracellular stress signals into the cytosol for the
purposes of metabolic control. By contrast in pathophysiological settings, VDAC closing may
spare oxidative stress in the cytosol while promoting intramitochondrial oxidative stress by
decreasing mitochondrial release of O2•-. In particular, intramitochondrial oxidative stress from
VDAC closure sensitizes mitochondria to the MPT and may cause downstream activation of







MIB mitochondrial incubation buffer
MOM mitochondrial outer membrane
MPT mitochondrial permeability transition
O2•- superoxide anion
PT permeability transition
RFU relative fluorescence unit
ROS reactive oxygen species
RT room temperature
SOD superoxide dismutase
VDAC voltage dependent anion channel.
Acknowledgments
This work was supported, in part, by Grants AA016011, K25 AA016604, DK37034 and DK073336 from the National
Institutes of Health and a Pilot Feasibility Grant from the Center of Gastrointestinal Biology and Disease, University
of North Carolina at Chapel Hill, Chapel Hill, NC USA.
Reference List
1. Andreyev A, Yu, Kushnareva YE, Starkov AA. Biochemistry, (Moscow) 2005;20:200–214. [PubMed:
15807660]
Tikunov et al. Page 10













2. Cadenas E, Davies KJ. Free Radic. Biol. Med 2000;29:222–230. [PubMed: 11035250]
3. Drose S, Brandt U. J Biol. Chem 2008;283:21649–21654. [PubMed: 18522938]
4. Inarrea P, Moini H, Han D, Rettori D, Aguilo I, Alava MA, Iturralde M, Cadenas E. Biochem. J
2007;405:173–179. [PubMed: 17394422]
5. Turrens JF. Biosci. Rep 1997;17:3–8. [PubMed: 9171915]
6. Han D, Williams E, Cadenas E. Biochem. J 2001;353:411–416. [PubMed: 11139407]
7. Piskernik C, Haindl S, Behling T, Gerald Z, Kehrer I, Redl H, Kozlov AV. Biochim. Biophys. Acta
2008;1782:280–285. [PubMed: 18298959]
8. Okado-Matsumoto A, Fridovich I. J Biol. Chem 2001;276:38388–38393. [PubMed: 11507097]
9. Weisiger RA, Fridovich I. J Biol. Chem 1973;248:4793–4796. [PubMed: 4578091]
10. Antunes F, Han D, Cadenas E. Free Radic. Biol. Med 2002;33:1260–1267. [PubMed: 12398934]
11. Cao Z, Lindsay JG, Isaacs NW. Subcell. Biochem 2007;44:295–315. [PubMed: 18084900]
12. Handy DE, Lubos E, Yang Y, Galbraith JD, Kelly N, Zhang YY, Leopold JA, Loscalzo J. J Biol.
Chem 2009;284:11913–11921. [PubMed: 19254950]
13. Jezek P, Hlavata L. Int. J Biochem. Cell Biol 2005;37:2478–2503. [PubMed: 16103002]
14. Lambert AJ, Brand MD. Methods Mol. Biol 2009;554:165–181. [PubMed: 19513674]
15. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N. Free Radic.
Biol. Med 2004;37:755–767. [PubMed: 15304252]
16. Goldsteins G, Keksa-Goldsteine V, Ahtoniemi T, Jaronen M, Arens E, Akerman K, Chan PH,
Koistinaho J. J Biol. Chem 2008;283:8446–8452. [PubMed: 18171673]
17. Dawson TL, Gores GJ, Nieminen AL, Herman B, Lemasters JJ. Am. J. Physiol 1993;264:C961–
C967. [PubMed: 8386454]
18. Madesh M, Hajnoczky G. J Cell Biol 2001;155:1003–1015. [PubMed: 11739410]
19. Han D, Antunes F, Canali R, Rettori D, Cadenas E. J Biol. Chem 2003;278:5557–5563. [PubMed:
12482755]
20. Karachitos A, Galganska H, Wojtkowska M, Budzinska M, Stobienia O, Bartosz G, Kmita H. FEBS
Lett 2009;583:449–455. [PubMed: 19116152]
21. Bernardi P, Forte M. Novartis. Found. Symp 2007;287:157–164. [PubMed: 18074637]
22. Crompton M, Virji S, Doyle V, Johnson N, Ward JM. Biochem. Soc. Symp 1999;66:167–179.
[PubMed: 10989666]
23. Haworth RA, Hunter DR. Arch. Biochem. Biophys 1979;195:460–467. [PubMed: 38751]
24. Hunter DR, Haworth RA. Arch. Biochem. Biophys 1979;195:468–477. [PubMed: 112926]
25. Gunter TE, Pfeiffer DR. Am. J. Physiol 1990;258:C755–C786. [PubMed: 2185657]
26. Halestrap AP. Biochem. Soc. Trans 2006;34:232–237. [PubMed: 16545083]
27. Lemasters JJ. Cardiovasc Res 1999;44:470–473. [PubMed: 10690277]
28. Nieminen AL, Byrne AM, Herman B, Lemasters JJ. Am J Physiol 1997;272:C1286–C1294.
[PubMed: 9142854]
29. Holmuhamedov E, Lemasters JJ. Arch. Biochem. Biophys 2009;481:226–233. [PubMed: 19014900]
30. Lemasters JJ, Holmuhamedov E. Biochim. Biophys. Acta 2006;1762:181–190. [PubMed: 16307870]
31. Colombini M. Mol Cell Biochem 2004;256–257:107–115.
32. Lai JC, Tan W, Benimetskaya L, Miller P, Colombini M, Stein CA. Proc. Natl. Acad. Sci. U. S. A
2006;103:7494–7499. [PubMed: 16648253]
33. Tan W, Loke YH, Stein CA, Miller P, Colombini M. Biophys. J 2007;93:1184–1191. [PubMed:
17483171]
34. Tan W, Lai JC, Miller P, Stein CA, Colombini M. Am J Physiol Cell Physiol 2007;292:C1388–C1397.
[PubMed: 17135295]
35. Lemasters JJ, Grunwald R, Emaus RK. J. Biol. Chem 1984;259:3058–3063. [PubMed: 6321493]
36. Hoek JB, Coll KE, Williamson JR. J Biol. Chem 1983;258:54–58. [PubMed: 6129254]
37. Broekemeier KM, Dempsey ME, Pfeiffer DR. J Biol. Chem 1989;264:7826–7830. [PubMed:
2470734]
Tikunov et al. Page 11













38. Kanno T, Sato EE, Muranaka S, Fujita H, Fujiwara T, Utsumi T, Inoue M, Utsumi K. Free Radic.
Res 2004;38:27–35. [PubMed: 15061651]
39. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Free Radic. Biol. Med 2004;37:1943–1950.
[PubMed: 15544914]
40. Lemasters JJ, Nieminen AL. Biosci. Rep 1997;17:281–291. [PubMed: 9337483]
41. Schnaitman C, Greenawalt JW. J. Cell Biol 1968;38:158–175. [PubMed: 5691970]
42. Becker GL, Fiskum G, Lehninger AL. J Biol. Chem 1980;255:9009–9012. [PubMed: 7410406]
43. Markevich NI, Hoek JB. Computational modeling of ROS production in mitochondria. 2009
44. Hackenbrock CR, Chazotte B, Gupte SS. J Bioenerg. Biomembr 1986;18:331–368. [PubMed:
3021714]
45. Hackenbrock CR. J Cell Biol 1966;30:269–297. [PubMed: 5968972]
46. Hackenbrock CR. J Cell Biol 1968;37:345–369. [PubMed: 5656397]
47. Lemasters JJ. FEBS Lett 1978;88:10–14. [PubMed: 639975]
48. Bielski BH, Cabelli DE. Int. J Radiat. Biol 1991;59:291–319. [PubMed: 1671684]
49. Battistuzzi G, Borsari M, Cowan JA, Eicken C, Loschi L, Sola M. Biochemistry 1999;38:5553–5562.
[PubMed: 10220343]
50. Sinibaldi F, Fiorucci L, Patriarca A, Lauceri R, Ferri T, Coletta M, Santucci R. Biochemistry
2008;47:6928–6935. [PubMed: 18540683]
51. Vanlier J, Wu F, Qi F, Vinnakota KC, Han Y, Dash RK, Yang F, Beard DA. Bioinformatics
2009;25:836–837. [PubMed: 19244386]
52. Wu F, Yang F, Vinnakota KC, Beard DA. J. Biol. Chem 2007;282:24525–24537. [PubMed:
17591785]
53. Tan W, Colombini M. Biochim. Biophys. Acta 2007;1768:2510–2515. [PubMed: 17617374]
54. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Nat. Cell Biol 2007;9:550–555.
[PubMed: 17417626]
55. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, Kalyanaraman B. Free
Radic. Biol. Med 2003;34:1359–1368. [PubMed: 12757846]
56. Georgiou CD, Papapostolou I, Patsoukis N, Tsegenidis T, Sideris T. Anal. Biochem 2005;347:144–
151. [PubMed: 16246291]
57. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, Pacher P. Biochem. Biophys. Res. Commun
2007;358:203–208. [PubMed: 17475217]
58. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR,
Gottlieb RA, Dorn GW, Robbins J, Molkentin JD. Nature 2005;434:658–662. [PubMed: 15800627]
59. Gincel D, Zaid H, Shoshan-Barmatz V. Biochem. J 2001;358:147–155. [PubMed: 11485562]
60. Battistuzzi G, Borsari M, Cowan JA, Ranieri A, Sola M. J Am Chem. Soc 2002;124:5315–5324.
[PubMed: 11996572]
61. Butler J, Jayson GG, Swallow AJ. Biochim. Biophys. Acta 1975;408:215–222. [PubMed: 60]
Tikunov et al. Page 12













Fig. 1. Increasing Ca2+ loading accelerates the occurrence of the MPT in mitochondria
A, Mitochondria (1 mg of protein/ml) were added to incubation buffer containing 200 mM
sucrose, 5 mM succinate, 2 µM rotenone, 1 µg/ml oligomycin, 1 mM KH2PO4, 20 µM EGTA,
20 mM Tris/HEPES buffer, pH 7.2, and exposed to various concentrations of Ca2+ (0, 100,
150, 200, 250, 300 µM, curve a through f, respectively). Onset of the MPT was monitored by
absorbance, as described in Materials and Methods. The long horizontal dashed lines mark
the levels of the maximal (Amax), minimal (Amin) and the median (A1/2) level of absorbance.
Vertical dashed lines mark the time points to 50% MPT for different Ca2+ concentrations. As
indicated, CsA (1 µM) was added with 300 µM Ca2+ (curve g, filled triangles). B, Dependence
of onset of MPT on Ca2+ concentration. The data shown are representative of at least four
independent experiments.
Tikunov et al. Page 13













Fig. 2. Closure of VDAC accelerates the occurrence of the Ca2+-induced MPT
A, Onset of 200 µM Ca2+-induced MPT in untreated mitochondria (curve c, open circles) and
mitochondria treated with 5 µM G3139 (curve d, open triangles). Shown also the changes in
the absorbance of mitochondria treated with G3139 in the absence of added Ca2+ (curve b,
open squares), and mitochondria treated with CsA and loaded with 200 µM Ca2+ (curve a,
filled triangles). B, Dependence of the onset of MPT on Ca2+ concentrations in control,
untreated (open circles) and 5 µM G3139-treated (open triangles) mitochondria. The data
shown are representative of at least four independent experiments, p<0.05.
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Fig. 3. Butylated hydroxytoluene (BHT) delays MPT occurrence and reverses the effect of G3139
A, Onset of 200 µM Ca2+-induced MPT in mitochondria under different conditions: no
treatment (curve c, open circles), treated with 5 µM G339 (curve a, open triangles), treated
with 20 µM BHT (curve b, filed squares) and treated with both, 5 µM G3139 and 20 µM BHT
(curve d, open squares). B, Ca2+ dose dependence of the onset of MPT in control (open
circles), G3139 treated (open triangles) and BHT treated (filed squares) mitochondria. The
dotted line (open squares) demonstrates the onset of MPT in mitochondria in the presence of
both, G3139 and BHT. The data shown are representative of at least four independent
experiments, p<0.05.
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Fig. 4. Closure of VDAC increases the level of superoxide anions in mitochondria
The rates of superoxide production in mitochondria with open (None, open bars) and closed
VDAC (G13139, filled bars). Mitochondria (1 mg/ml) were incubated in the buffer containing
200 mM sucrose, 5 mM succinate, 2 µM rotenone, 1 µg/ml oligomycin, 1 mM KH2PO4, 20
µM EGTA, 20 mM Tris/HEPES, pH 7.4 and was supplemented with antimycin A (1 µg/ml).
Shown the level of superoxide in both, control and G3139-treated mitochondria in the absence
(− SOD) and presence (+ SOD) of superoxide dismutase. The data shown are representative
of at least three independent experiments, p<0.05.
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Fig. 5. Closure of VDAC decreases the uptake of Calcein into IMS of mitochondria
Accumulation and retention of VDAC permeating fluorescent molecules of Calcein (MW
622.5) in mitochondria (1 mg/ml) with open (None, open bars) and closed VDAC (G3139,
filled bars). Mitochondria (1 mg/ml) were incubated in the buffer containing 200 mM sucrose,
5 mM succinate, 2 µM rotenone, 1 µg/ml oligomycin, 1 mM KH2PO4, 20 µM EGTA, 20 mM
Tris/HEPES, pH 7.4 supplemented with 40 µM of Calcein. Shown are Calcein fluorescence
remained with mitochondria following centrifugation of the through the silicone oil (14,000 ×
g, 60 s) in the absence (− DIG) and presence (+ DIG) of digitonin. The data shown are
representative of at least three independent experiments, p<0.05.
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Fig. 6. Closure of VDAC does not decrease Ca2+- uptake in mitochondria
Acceleration of oxygen consumption in mitochondria (1 mg/ml) with open (None, open
bars) and closed VDAC (G3139, filed bars). Mitochondria (1 mg/ml) were incubated in the
buffer containing 200 mM sucrose, 5 mM succinate, 2 µM rotenone, 1 µg/ml oligomycin, 1
mM KH2PO4, 20 µM EGTA, 20 mM Tris/HEPES, pH 7.4 and exposed to 250 µM CaCl2.
Shown are the respiration of mitochondria in the absence (− Ca2+) and presence (+ Ca2+) of
CaCl2. The data shown are representative of at least three independent experiments, p<0.05.
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Fig. 7. Simplified diagram of O2•-˜ generation and utilization within IMS of mitochondria
Complex III of the respiratory chain located within the inner mitochondrial membrane
(IMM) releases superoxide into the Matrix and into the Intermembrane space. Matrix
superoxide is detoxified by mitochondrial Mn-SOD, and IMS superoxide participates in the
reaction of spontaneous dismutation (JDis), reduction of the cytochrome c (Jcyt c) and/or leaves
IMS (JVDAC) through the open VDAC in the outer mitochondrial membrane (OMM). VDAC
blocker (G3139) closes VDAC and impedes the efflux of superoxide from IMS. These
processes of generation and annihilation of O2•-˜ within the IMS of mitochondria were used
for mathematical modeling of superoxide metabolism in mitochondria.
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Fig. 8. Predicted steady-state concentration of O2•- within the IMS as function of open/closed status
of VDAC ̃
Computer simulated steady statẽ concentration of O2•- within IMS upon progressive closure
of VDAC (dotted line). The range of expected steady state concentrations of O2•-˜ for
permeability of VDAC approximated from available experimental data shown as solid segment
of the entire curve. Dotted line also extrapolated to the concentrations of O2•- within IMS with
completely closed VDAC (intersection at PVDAC = 0).
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Table 1
Parameters of the model
No Item (constant, flux, etc) Value (nmoles, s−1, etc) Source
1 Turnover number for superoxide generation
by isolated cytochrome bc1 complex, kbc1
1 s−1 (determined in the
presence of Antimycin A)
(3)
2 Concentration of bc1 complexes per mg of
mitochondrial protein
0.041 nmol/mg protein (44)
3 Volume fraction of mitochondria to IMS
(Vmit)/VIMS)
2 (44)
4 Rate constant of spontaneous dismutation
(kdis)
0.6 µM−1s−1 (48)
5 Midpoint potential of cytochrome c(Fe3+)/
(Fe2+)
+ 260 mV (49,60)
6 Midpoint potential of O2/O2•- − 150 mV (49,60)
7 The rate constant of cytochrome c oxidation
of O2•- (kcyt c)
1 µM−1s−1 (61)
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